To date, it has been found that AURKB is highly expressed in various malignant tumors, including colon adenocarcinoma, thyroid follicular carcinoma, laryngeal carcinoma, lung cancer, and breast invasive ductal carcinoma [39–42]. Here, AURKB is linked to thyroid gland follicular carcinoma.